Supplementary Tables 1 - 4 from Inactivation of the &lt;i&gt;CDKN2A&lt;/i&gt; Tumor-Suppressor Gene by Deletion or Methylation Is Common at Diagnosis in Follicular Lymphoma and Associated with Poor Clinical Outcome